Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
- PMID: 36126688
- PMCID: PMC9568277
- DOI: 10.1053/j.gastro.2022.09.008
Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
Figures
Comment in
-
Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System.Gastroenterology. 2023 Jul;165(1):305-306. doi: 10.1053/j.gastro.2023.02.008. Epub 2023 Feb 18. Gastroenterology. 2023. PMID: 36801390 Free PMC article. No abstract available.
References
-
- National Institute of Diabetes and Digestive and Kidney Diseases, 2012. https://www.ncbi.nlm.nih.gov/books/NBK547852/. Accessed August 31, 2022.
-
- Yip T.C., et al. J Hepatol. 2022;76:726–734. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources